{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:37:59Z","timestamp":1791308279712,"version":"4.3.1"},"update-to":[{"DOI":"10.1002\/14651858.cd003160.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,1,4]],"date-time":"2016-01-04T00:00:00Z","timestamp":1451865600000}}],"reference-count":105,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003160.pub3","type":"journal-article","created":{"date-parts":[[2016,1,4]],"date-time":"2016-01-04T14:44:07Z","timestamp":1451918647000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":129,"title":["Statins for the prevention of dementia"],"prefix":"10.1002","volume":"2016","author":[{"given":"Bernadette","family":"McGuinness","sequence":"first","affiliation":[{"name":"Queen's University Belfast; Centre for Public Health; Institute of Clinical Sciences, Block B Grosvenor Road Belfast Co Antrim UK BT12 6BA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Craig","sequence":"additional","affiliation":[{"name":"Craigavon Area Hospital; Geriatric Medicine; Craigavon Northern Ireland UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Bullock","sequence":"additional","affiliation":[{"name":"Kingshill Research Centre, Victoria Hospital; Okus Road Swindon UK SN4 4HZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Passmore","sequence":"additional","affiliation":[{"name":"Queen's University Belfast; Centre for Public Health; Institute of Clinical Sciences, Block B Grosvenor Road Belfast Co Antrim UK BT12 6BA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,1,4]]},"reference":[{"key":"10.1002\/14651858.CD003160.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","author":"Heart Protection Study Collaborative Group","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1111\/j.1532-5415.2007.01415.x","article-title":"Association between apolipoprotein E4 and cognitive decline in elderly adults","volume":"11","author":"Packard","year":"2007","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0002-9149(99)00533-0","article-title":"The design of a prospective study of pravastatin in the elderly at risk (PROSPER)","volume":"84","author":"Shepherd","year":"1999","journal-title":"American Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD003160.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00415-009-5271-7","article-title":"Pravastatin and cognitive function in the elderly. Results of the PROSPER study","volume":"257","author":"Trompet","year":"2010","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0002-9343(00)00353-3","article-title":"Effects of lovastatin on cognitive function and psychological well-being","volume":"108","author":"Muldoon","year":"2000","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.amjmed.2004.07.041","article-title":"Randomized trial of the effects of simvastatin on cognitive functioning in hypercholesterolemic adults","volume":"117","author":"Muldoon","year":"2004","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archinte.1994.00420050081008","article-title":"Cholesterol lowering in the elderly. results of the Cholesterol Reduction In Seniors Program (CRISP) pilot study","volume":"154","author":"LaRosa","year":"1994","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1532-5415.1997.tb00971.x","article-title":"Effect of pharmacologic lipid lowering on health-related quality of life in older persons: results from the Cholesterol Reduction In Seniors Program (CRISP) pilot study","volume":"45","author":"Santanello","year":"1997","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000295660","article-title":"Cholesterol and cognitive performance in normal controls and the influence of elective statin use after conversion to mild cognitive impairment: results in a clinical trial cohort","volume":"7","author":"Sparks","year":"2010","journal-title":"Neuro-degenerative Diseases"},{"issue":"2","key":"10.1002\/14651858.CD003160.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1592\/phco.27.2.183","article-title":"Effect of atorvastatin on cognitive function in patients from the Lipid Lowering and Onset of Renal Disease (LORD) trial","volume":"27","author":"Summers","year":"2007","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1002\/14651858.CD003160.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/gps.2688","article-title":"One-year cholesterol lowering treatment reduces medial temporal lobe atrophy and memory decline in stroke-free elderly with atrial fibrillation: evidence from a parallel group randomized trial","volume":"27","author":"Tendolkar","year":"2012","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1097\/HJH.0000000000000254","article-title":"Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension - Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial","volume":"32","author":"Zanchetti","year":"2014","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/1745-6215-14-401","article-title":"Prevention of Decline in Cognition after Stroke Trial (PODCAST): a study protocol for a factorial randomised controlled trial of intensive versus guideline lowering of blood pressure and lipids","volume":"14","author":"Blackburn","year":"2013","journal-title":"Trials"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0015|cit15","first-page":"11","article-title":"Baseline subjective memory complaints associate with increased risk of incident dementia: the PREADVISE trial","volume":"2","author":"Abner","year":"2015","journal-title":"Journal of Prevention of Alzheimer's Disease"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1161\/STROKEAHA.108.546135","article-title":"Relative and cumulative effects of lipid and blood pressure control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels trial","volume":"40","author":"Amarenco","year":"2009","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000017215","article-title":"Neuropathological substrates of dementia and depression in vascular dementia, with a particular focus on cases with small infarct volumes","volume":"11","author":"Ballard","year":"2000","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"issue":"9","key":"10.1002\/14651858.CD003160.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"e1004606","DOI":"10.1371\/journal.pgen.1004606","article-title":"Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias","volume":"10","author":"Beecham","year":"2014","journal-title":"PLoS Genetics"},{"issue":"6","key":"10.1002\/14651858.CD003160.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.11.002","article-title":"Statins, risk of dementia and cognitive function: secondary analysis of the ginkgo evaluation of memory study","volume":"21","author":"Bettermann","year":"2012","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"issue":"11","key":"10.1002\/14651858.CD003160.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1136\/jech.2009.100826","article-title":"Statins and serum cholesterol's associations with incident dementia and mild cognitive impairment","volume":"65","author":"Beydoun","year":"2011","journal-title":"Journal of Epidemiology and Community Health"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1161\/01.STR.0000091396.95360.E1","article-title":"Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial","volume":"34","author":"Black","year":"2003","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD003160.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1517\/14740331003662620","article-title":"Statin use and cancer risk: a comprehensive review","volume":"9","author":"Bondreau","year":"2010","journal-title":"Expert Opinions on Drug Safety"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1212\/WNL.44.7.1246","article-title":"Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: The Rotterdam Study","volume":"44","author":"Breteler","year":"1994","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0169-328X(02)00647-2","article-title":"Co-localization of cholesterol, apolipoprotein E and fibrillar Abeta in amyloid plaques","volume":"110","author":"Burns","year":"2003","journal-title":"Brain Research. Molecular Brain Research"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"b75","DOI":"10.1136\/bmj.b75","article-title":"Dementia","volume":"338","author":"Burns","year":"2009","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1750-1326-2-22","article-title":"The Alzheimer's disease beta-secretase enzyme, BACE1","volume":"2","author":"Cole","year":"2007","journal-title":"Molecular Neurodegeneration"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomized trials of statins","volume":"366","author":"Cholesterol Treatment Trialists' Collaborators","year":"2005","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.2002.tb04802.x","article-title":"Paraoxonase 1 activity: a new vascular marker of dementia?","volume":"977","author":"Dantoine","year":"2002","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1083\/jcb.200207113","article-title":"Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts","volume":"160","author":"Ehehalt","year":"2003","journal-title":"Journal of Cell Biology"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/jnnp.63.6.749","article-title":"Neuropathological assessment of the lesions of significance in vascular dementia","volume":"63","author":"Esiri","year":"1997","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD003160.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1592\/phco.29.7.800","article-title":"Statin-associated adverse cognitive effects: survey results from 171 patients","volume":"29","author":"Evans","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. ApoE and Alzheimer Disease Meta Analysis Consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"20","author":"Glenner","year":"1984","journal-title":"Biochemistry Biophysics Research Communications"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/archneur.57.10.1410","article-title":"Is there a connection between the concentration of cholesterol circulating in plasma and the rate of neuritic plaque formation in Alzheimer's disease","volume":"57","author":"Haley","year":"2000","journal-title":"Archives of Neurology"},{"issue":"10","key":"10.1002\/14651858.CD003160.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nature Genetics"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.plefa.2004.06.001","article-title":"Statin treatment alters serum n-3 and n-6 fatty acids in hypercholesterolemic patients","volume":"71","author":"Harris","year":"2004","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids"},{"issue":"2","key":"10.1002\/14651858.CD003160.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/01.wad.0000213814.43047.86","article-title":"Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study","volume":"20","author":"Hayden","year":"2006","journal-title":"Alzheimer Disease and Associated Disorders"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/heartjnl-2014-305693","article-title":"Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3)","volume":"100","author":"JBS3","year":"2014","journal-title":"Heart"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1212\/WNL.45.6.1092","article-title":"Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case control study","volume":"45","author":"Jarvik","year":"1995","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000375366","article-title":"Prevalence of dementia and main subtypes in rural northern China","volume":"39","author":"Ji","year":"2015","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(00)03155-X","article-title":"Statins and the risk of dementia","volume":"356","author":"Jick","year":"2000","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD003160.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1161\/01.ATV.20.10.2255","article-title":"Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study","volume":"20","author":"Kalmijn","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1002\/14651858.CD003160.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s40263-014-0147-5","article-title":"Cognitive effects of statin medications","volume":"28","author":"Kelley","year":"2014","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1002\/14651858.CD003160.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.7326\/0003-4819-137-3-200208060-00006","article-title":"Apolipoprotein E \u025b4 allele, elevated midlife total cholesterol level and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer's disease","volume":"137","author":"Kivipelto","year":"2002","journal-title":"Annals of Internal Medicine"},{"issue":"10","key":"10.1002\/14651858.CD003160.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/archneur.62.10.1556","article-title":"Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease","volume":"62","author":"Kivipelto","year":"2005","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0047|cit47","first-page":"269","article-title":"Vascular dementia and systemic changes [in Polish]","volume":"59","author":"Klich-Raczka","year":"2002","journal-title":"Przegla\u0327d Lekarski"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0048|cit48","first-page":"589","article-title":"Low levels of serum apolipoprotein A I and A II in senile dementia","volume":"48","author":"Kuriyama","year":"1994","journal-title":"Japanese Journal of Psychiatry and Neurology"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1532-5415.2005.53015.x","article-title":"Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by cholinesterase inhibition","volume":"53","author":"Lopez","year":"2005","journal-title":"Journal of the American Geriatric Society"},{"issue":"1","key":"10.1002\/14651858.CD003160.pub3-BIB0050|cit50","first-page":"36","article-title":"Cholesterol, transferrin saturation, and the development of dementia and Alzheimer's disease: results from an 18-year population-based cohort","volume":"37","author":"Mainous","year":"2005","journal-title":"Family Medicine"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1023\/A:1023211323853","article-title":"APP processing enzymes (secretases) as therapeutic targets: insights from the use of transgenics (tgs) and transfected cells","volume":"28","author":"Marks","year":"2003","journal-title":"Neurochemistry Research"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"20607","DOI":"10.3390\/ijms151120607","article-title":"Molecular mechanisms underlying the effects of statins in the central nervous system","volume":"15","author":"McFarland","year":"2014","journal-title":"International Journal of Molecular Sciences"},{"issue":"17","key":"10.1002\/14651858.CD003160.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1097\/WNR.0b013e3282f13e7a","article-title":"Association between SORL1 and Alzheimer's disease in a genome-wide study","volume":"18","author":"Meng","year":"2007","journal-title":"Neuroreport"},{"issue":"10","key":"10.1002\/14651858.CD003160.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1212\/01.WNL.0000161870.78572.A5","article-title":"High total cholesterol levels in late life associated with a reduced risk of dementia","volume":"64","author":"Mielke","year":"2005","journal-title":"Neurology"},{"issue":"21","key":"10.1002\/14651858.CD003160.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1212\/WNL.0b013e3181feb2bf","article-title":"The 32-year relationship between cholesterol and dementia from midlife to late life","volume":"75","author":"Mielke","year":"2010","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"15110","DOI":"10.1074\/jbc.274.21.15110","article-title":"Cholesterol-dependent generation of a seeding amyloid beta-protein in cell culture","volume":"274","author":"Mizuno","year":"1999","journal-title":"Journal of Biological Chemistry"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1001\/jama.282.3.254","article-title":"Low-density lipoprotein cholesterol and the risk of dementia with stroke","volume":"282","author":"Moroney","year":"1999","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(85)92866-1","article-title":"High-density lipoprotein cholesterol in differential diagnosis of senile dementia","volume":"1","author":"Muckle","year":"1985","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0896-6273(95)90079-9","article-title":"Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain","volume":"15","author":"Naslund","year":"1995","journal-title":"Neuron"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0060|cit60","unstructured":"Dementia. supporting people with dementia and their carers in health and social care. NICE clinical guideline 42, November 2006. Available at: http:\/\/www.guidance.nice.org.uk\/CG42."},{"key":"10.1002\/14651858.CD003160.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000026149","article-title":"Serum total cholesterol, apolipoprotein E \u01904 allele and Alzheimer's disease","volume":"17","author":"Notkola","year":"1998","journal-title":"Neuroepidemiology"},{"issue":"6","key":"10.1002\/14651858.CD003160.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1592\/phco.21.7.767.34577","article-title":"Simvastatin-associated memory loss","volume":"21","author":"Orsi","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/S0140-6736(97)07541-7","article-title":"Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam study","volume":"351","author":"Ott","year":"1998","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD003160.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11606-014-3115-3","article-title":"Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials","volume":"30","author":"Ott","year":"2015","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s004060200013","article-title":"Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia","volume":"252","author":"Paragh","year":"2002","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1212\/WNL.58.8.1175","article-title":"The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function","volume":"58","author":"Posner","year":"2002","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0067|cit67","unstructured":"Prince M Albanese E Guerchet M Prina M World Alzheimer report 2014. Dementia and risk reduction. An analysis of protective and modifiable factors, 2014 www.alz.co.uk\/research\/world-report-2014"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0068|cit68","first-page":"321","article-title":"Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model","volume":"7","author":"Refolo","year":"2000","journal-title":"Neurobiological Disorders"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archneur.61.5.705","article-title":"Relation of plasma lipids to Alzheimer disease and vascular dementia","volume":"61","author":"Reitz","year":"2004","journal-title":"Archives of Neurology"},{"issue":"10","key":"10.1002\/14651858.CD003160.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"688","DOI":"10.7326\/0003-4819-159-10-201311190-00007","article-title":"Statins and cognitive function: a systematic review","volume":"159","author":"Richardson","year":"2013","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"908915","DOI":"10.1155\/2014\/908915","article-title":"Global epidemiology of dementia: Alzheimer's and vascular types","volume":"2014","author":"Rizzi","year":"2014","journal-title":"BioMed Research International"},{"issue":"3","key":"10.1002\/14651858.CD003160.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1212\/WNL.53.3.517","article-title":"APOE genotype, plasma lipids, lipoproteins, and AD in community elderly","volume":"53","author":"Romas","year":"1999","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1046\/j.1532-5415.2002.50631.x","article-title":"New possible role of statins in age-related diseases","volume":"50","author":"Ruocco","year":"2002","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0074|cit74","unstructured":"Schunemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1161\/01.ATV.14.7.1098","article-title":"Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk In Communities (ARIC) study","volume":"14","author":"Sharrett","year":"1994","journal-title":"Arteriosclerosis and Thrombosis"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1073\/pnas.95.11.6460","article-title":"Cholesterol depletion inhibits the generation of B-amyloid in hippocampal neurons","volume":"95","author":"Simons","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000026147","article-title":"Status of risk factors for vascular dementia","volume":"17","author":"Skoog","year":"1998","journal-title":"Neuroepidemiology"},{"issue":"10","key":"10.1002\/14651858.CD003160.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1212\/01.wnl.0000256368.57375.b7","article-title":"Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study","volume":"68","author":"Solomon","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD003160.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000231980","article-title":"Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later","volume":"28","author":"Solomon","year":"2009","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"issue":"4","key":"10.1002\/14651858.CD003160.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/ggi.12044","article-title":"Association of statin use with risk of dementia: a meta-analysis of prospective cohort studies","volume":"13","author":"Song","year":"2013","journal-title":"Geriatrics & Gerontology International"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa061894","article-title":"High-dose atorvastatin after stroke or transient ischaemic attack","volume":"355","author":"SPARCL Investigators","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/exnr.1994.1044","article-title":"Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol","volume":"126","author":"Sparks","year":"1994","journal-title":"Experimental Neurology"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1464-5491.1999.00027.x","article-title":"Type 2 diabetes mellitus, cognitive impairment and dementia","volume":"16","author":"Stewart","year":"1999","journal-title":"Diabetic Medicine"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1001\/archneur.64.1.103","article-title":"Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study","volume":"64","author":"Stewart","year":"2007","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","article-title":"Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"11","key":"10.1002\/14651858.CD003160.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.mayocp.2013.07.013","article-title":"Statins and cognition: a systematic review and meta-analysis of short- and long-term cognitive effects","volume":"88","author":"Swiger","year":"2013","journal-title":"Mayo Clinic Proceedings"},{"issue":"9","key":"10.1002\/14651858.CD003160.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/archinte.163.9.1053","article-title":"Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study","volume":"163","author":"Tan","year":"2003","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/ana.10220","article-title":"Association between high-density lipoprotein and cognitive impairment in the oldest old","volume":"51","author":"Exel","year":"2002","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"44945","DOI":"10.1074\/jbc.M407986200","article-title":"Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes","volume":"279","author":"Vetrivel","year":"2004","journal-title":"Journal of Biological Chemistry"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1592\/phco.23.7.871.32720","article-title":"Statin-associated memory loss: analysis of 60 case reports and review of the literature","volume":"23","author":"Wagstaff","year":"2003","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1002\/14651858.CD003160.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"e92388","DOI":"10.1371\/journal.pone.0092388","article-title":"Statins for the prevention of stroke: a meta-analysis of randomized controlled trials","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1161\/01.HYP.37.6.1450","article-title":"HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species","volume":"37","author":"Wassmann","year":"2001","journal-title":"Hypertension"},{"issue":"2","key":"10.1002\/14651858.CD003160.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1212\/01.WNL.0000149519.47454.F2","article-title":"Midlife cardiovascular risk factors and risk of dementia in late life","volume":"64","author":"Whitmer","year":"2005","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/01.WNL.0000078943.50032.FC","article-title":"Donepezil in vascular dementia: a randomized, placebo-controlled study","volume":"61","author":"Wilkinson","year":"2003","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(95)90701-7","article-title":"Is Alzheimer's disease an apolipoprotein E amyloidosis?","volume":"345","author":"Wisniewski","year":"1995","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","article-title":"Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors","volume":"57","author":"Wolozin","year":"2000","journal-title":"Archives of Neurology"},{"issue":"4","key":"10.1002\/14651858.CD003160.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/pds.3381","article-title":"Statins in the prevention of dementia and Alzheimer's disease: a meta-analysis of observational studies and an assessment of confounding","volume":"22","author":"Wong","year":"2013","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0098|cit98","unstructured":"Alzheimer\u2019s Disease International World Alzheimer Report 2009.London: Alzheimer\u2019s Disease International 2009"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0099|cit99","unstructured":"Prince M Wimo A Guerchet M Ali GC Wu YT Prina M World Alzheimer Report 2015"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1212\/WNL.45.6.1161","article-title":"Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama study","volume":"45","author":"Yoshitake","year":"1995","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000073981","article-title":"Association between statin use and Alzheimer's disease","volume":"23","author":"Zamrini","year":"2004","journal-title":"Neuroepidemiology"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archpsyc.62.2.217","article-title":"Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study","volume":"62","author":"Zandi","year":"2005","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD003160.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2318-1-5","article-title":"Lipoprotein profile in older patients with vascular dementia and Alzheimer's disease","volume":"1","author":"Zuliani","year":"2001","journal-title":"BMC Geriatrics"},{"issue":"2","key":"10.1002\/14651858.CD003160.pub3-BIB0104|cit104","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003160.pub2","article-title":"Statins for the prevention of dementia","author":"McGuinness","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD003160.pub3-BIB0105|cit105","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003160","article-title":"Statins for the prevention of Alzheimer's disease","author":"Scott","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD003160.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T03:20:20Z","timestamp":1680837620000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003160.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Dementia and Cognitive Improvement Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,1,4]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003160.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,4]]}}}